DIVERSITY BY DESIGN

Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Mar 2025)

What this means for you

This application is over — abandoned 31 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97593425
Mark type
Stylized text
Filed
15 Sept 2022
Published for opposition
03 Jan 2023
Abandoned
31 Mar 2025
Attorney of record
Michael A. Geller

Goods and services

  • Class 035 — Advertising and business services: Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
  • Class 041 — Education and entertainment services: Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and providing podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts
  • Class 042 — Scientific and technological services: Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development
  • Class 044 — Medical, beauty and agricultural services: Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications

Owner

Prosecution history

  • 31 Mar 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 31 Mar 2025 — ABANDONMENT - NO USE STATEMENT FILED
  • 10 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Dec 2024 — SOU EXTENSION 3 GRANTED
  • 28 Aug 2024 — SOU EXTENSION 3 FILED
  • 09 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 13 Sept 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
  • 13 Sept 2024 — NOTICE OF REVIVAL - E-MAILED
  • 13 Sept 2024 — PETITION TO REVIVE-GRANTED
  • 13 Sept 2024 — TEAS PETITION TO REVIVE RECEIVED
  • 29 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 28 Feb 2024 — SOU EXTENSION 2 GRANTED
  • 28 Feb 2024 — SOU EXTENSION 2 FILED
  • 28 Feb 2024 — SOU TEAS EXTENSION RECEIVED
  • 24 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Marksy